Literature DB >> 15949637

Peripheral injection of sauvagine prevents repeated colorectal distension-induced visceral pain in female rats.

Mulugeta Million1, Céline Maillot, David A Adelson, Tsukasa Nozu, Ariane Gauthier, Jean Rivier, George P Chrousos, Alfred Bayati, Hillevi Mattsson, Yvette Taché.   

Abstract

We investigated the effects of peripheral injection of sauvagine, a CRF2>CRF1 receptor (corticotropin-releasing factor) agonist compared with CRF, on two sets of tonic colorectal distension (CRDs 30, 40, 50 mmHg, 3-min on/off)-induced visceromotor response (VMR) measured as area under the curve (AUC) of abdominal muscle contraction in conscious female rats. Sauvagine (10 or 20 microg/kg, s.c.) abolished the 226.7+/-64.3% and 90.4+/-38.1% increase in AUC to the 2nd CRD compared with the 1st CRD (performed 30 min before) in female Fisher and Sprague-Dawley (SD) rats, respectively. CRF had no effect while the CRF1 antagonist, antalarmin (20 mg/kg, s.c.), alone or with sauvagine, blocked the enhanced response to the 2nd CRD, performed 60 min after the 1st CRD, and reduced further the AUC by 33.5+/-23.3% and 63.5+/-7.2%, respectively in Fisher rats. These data suggest that peripheral CRF2 receptor activation exerts antinociceptive effects on CRD-induced visceral pain, whereas CRF1 contributes to visceral sensitization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15949637     DOI: 10.1016/j.peptides.2005.02.004

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  17 in total

1.  Colorectal distention induces acute and delayed visceral hypersensitivity: role of peripheral corticotropin-releasing factor and interleukin-1 in rats.

Authors:  Tsukasa Nozu; Shima Kumei; Saori Miyagishi; Kaoru Takakusaki; Toshikatsu Okumura
Journal:  J Gastroenterol       Date:  2015-03-26       Impact factor: 7.527

Review 2.  Stress and visceral pain: from animal models to clinical therapies.

Authors:  Muriel Larauche; Agata Mulak; Yvette Taché
Journal:  Exp Neurol       Date:  2011-05-06       Impact factor: 5.330

3.  Enhanced pelvic responses to stressors in female CRF-overexpressing mice.

Authors:  M Million; L Wang; M P Stenzel-Poore; S C Coste; P Q Yuan; C Lamy; J Rivier; T Buffington; Y Taché
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-12-28       Impact factor: 3.619

Review 4.  Brain and Gut CRF Signaling: Biological Actions and Role in the Gastrointestinal Tract.

Authors:  Yvette Tache; Muriel Larauche; Pu-Qing Yuan; Mulugeta Million
Journal:  Curr Mol Pharmacol       Date:  2018       Impact factor: 3.339

Review 5.  Corticotropin-releasing factor receptor type 1 and type 2 interaction in irritable bowel syndrome.

Authors:  Tsukasa Nozu; Toshikatsu Okumura
Journal:  J Gastroenterol       Date:  2015-05-12       Impact factor: 7.527

6.  Corticotropin-releasing factor induces rectal hypersensitivity after repetitive painful rectal distention in healthy humans.

Authors:  Tsukasa Nozu; Miwako Kudaira
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

Review 7.  Corticotrophin-releasing factor 1 activation in the central amygdale and visceral hyperalgesia.

Authors:  Y Taché
Journal:  Neurogastroenterol Motil       Date:  2015-01       Impact factor: 3.598

Review 8.  Corticotropin-releasing factor signaling and visceral response to stress.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Exp Biol Med (Maywood)       Date:  2010-10

9.  Cortagine, a CRF1 agonist, induces stresslike alterations of colonic function and visceral hypersensitivity in rodents primarily through peripheral pathways.

Authors:  Muriel Larauche; Guillaume Gourcerol; Lixin Wang; Karina Pambukchian; Stefan Brunnhuber; David W Adelson; Jean Rivier; Mulugeta Million; Yvette Taché
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-30       Impact factor: 4.052

Review 10.  From Hans Selye's discovery of biological stress to the identification of corticotropin-releasing factor signaling pathways: implication in stress-related functional bowel diseases.

Authors:  Yvette Taché; Stefan Brunnhuber
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.